---
title: "OrganaBio: The Supply Brain | Carlos Carballosa"
description: Carlos Carballosa is a biomedical engineer with over 8 years of stem cell research experience with broad expertise in the culture, differentiation, and cryopreservation of adult stem cell populations. Carlos earned his bachelors, masters and doctorate degrees in Biomedical Engineering from the University of Miami, where his research focused on the effects of nicotine and electronic cigarette vapor exposure on the regeneration potential of adult stem cells.
---

[![OrganaBio-logo-rev-white-copy](https://blog.organabio.com/hs-fs/hubfs/OrganaBio-logo-rev-white-copy.png?width=979&height=239&name=OrganaBio-logo-rev-white-copy.png "OrganaBio-logo-rev-white-copy")](https://www.organabio.com)

![brain](https://blog.organabio.com/hubfs/marketing/brain.png "brain")

# The Supply Brain

Addressing supply chain challenges in cell and gene therapy.

The OrganaBio Blog

## Carlos Carballosa

![Carlos Carballosa](https://blog.organabio.com/hubfs/Imported%20images/Carlos.jpg)

Carlos Carballosa is a biomedical engineer with over 8 years of stem cell research experience with broad expertise in the culture, differentiation, and cryopreservation of adult stem cell populations. Carlos earned his bachelors, masters and doctorate degrees in Biomedical Engineering from the University of Miami, where his research focused on the effects of nicotine and electronic cigarette vapor exposure on the regeneration potential of adult stem cells.

### Recent Posts

## [MSC-Based Therapies for COVID-19](https://blog.organabio.com/en/mscs/msc-based-therapies-for-covid-19)

 Posted by [Carlos Carballosa](https://blog.organabio.com/en/author/carlos) on August 11, 2020

- [Tweet](https://twitter.com/share)

### **MSC-Based Therapies for COVID-19: Current Clinical Trial Landscape Data**

Mesenchymal stem/stromal cells (MSCs) are emerging as a potential treatment modality for COVID-191-3. MSCs have immunomodulatory properties that can be used to combat the inflammatory response caused by the SARS-CoV-2 coronavirus, and the United States Food and Drug Administration (FDA) has granted accelerated approvals to several MSC-based clinical trials for COVID-19. This brief blog post summarizes the current MSC COVID-19 clinical trial landscape based on data from clinicaltrials.gov.

[Read More](https://blog.organabio.com/en/mscs/msc-based-therapies-for-covid-19)

 0 Comments **//** [View or add comments](https://blog.organabio.com/en/mscs/msc-based-therapies-for-covid-19#comments-listing)

 Topics: [Allogeneic Cell Therapy](https://blog.organabio.com/en/tag/allogeneic-cell-therapy), [covid-19](https://blog.organabio.com/en/tag/covid-19), [MSCs](https://blog.organabio.com/en/tag/mscs)

[All posts](https://blog.organabio.com/en/all)

Add a Comment

### Recent Posts

### Posts by Tag

- [Allogeneic Cell Therapy (7)](https://blog.organabio.com/en/tag/allogeneic-cell-therapy)
- [Immune Cells (4)](https://blog.organabio.com/en/tag/immune-cells)
- [MSCs (4)](https://blog.organabio.com/en/tag/mscs)
- [OrganaBio (3)](https://blog.organabio.com/en/tag/organabio)
- [covid-19 (3)](https://blog.organabio.com/en/tag/covid-19)
- [Hematopoietic Stem Cells (2)](https://blog.organabio.com/en/tag/hematopoietic-stem-cells)
- [B cells (1)](https://blog.organabio.com/en/tag/b-cells)
- [Exosomes (1)](https://blog.organabio.com/en/tag/exosomes)
- [Gene Editing (1)](https://blog.organabio.com/en/tag/gene-editing)
- [Immunotherapy (1)](https://blog.organabio.com/en/tag/immunotherapy)
- [NK cells (1)](https://blog.organabio.com/en/tag/nk-cells)
- [Starting Materials (1)](https://blog.organabio.com/en/tag/starting-materials-cell-gene-therapy)
- [T cells (1)](https://blog.organabio.com/en/tag/t-cells)
- [Uncategorized (1)](https://blog.organabio.com/en/tag/uncategorized)
- [cGMP Manufacturing (1)](https://blog.organabio.com/en/tag/cgmp-manufacturing-of-cell-and-gene-therapies)
- [donor variability (1)](https://blog.organabio.com/en/tag/donor-variability)
- [iPSCs (1)](https://blog.organabio.com/en/tag/ipscs)
- [immunomodulation (1)](https://blog.organabio.com/en/tag/immunomodulation)
- [mesenchymal stromal cells (1)](https://blog.organabio.com/en/tag/mesenchymal-stromal-cells)
- [supply chain (1)](https://blog.organabio.com/en/tag/supply-chain)

See all